Market Place
Sourcing Support
All News #Library
Biotech
BioAegis Gets Fast Track for Gelsolin in Decompression Sickness
20 Aug 2025 //
GLOBENEWSWIRE
BioAegis Receives FDA Fast Track Designation for Lead Product
17 Jun 2025 //
GLOBENEWSWIRE
BioAegis Therapeutics gets US Navy contract for Phase 2 study of
10 Jun 2025 //
GLOBENEWSWIRE
BioAegis Therapeutics Starts Ph 2b Trial in 13 Countries for ARDS
06 May 2025 //
GLOBENEWSWIRE
BioAegis Therapeutics to Highlight Gelsolin`s Role at Conferences
18 Mar 2025 //
GLOBENEWSWIRE
BioAegis Enrolls First Patient In ARDS Phase 2 Trial Of Gelsolin
22 Oct 2024 //
GLOBENEWSWIRE
BioAegis Enrolls First Patient In ARDS Trial Of Gelsolin
17 Oct 2024 //
GLOBENEWSWIRE
BioAegis To Present At MedInvest Biotech & Pharma Investor Conference
12 Sep 2024 //
GLOBENEWSWIRE
BioAegis Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin
16 Oct 2023 //
GLOBENEWSWIRE
BioAegis Announces Studies Exploring the Role of Inflammation Regulator Gelsolin
13 Apr 2023 //
GLOBENEWSWIRE
BioAegis Announces Clearance of IND for Inflammation Regulator Protein Gelsolin
26 Jan 2023 //
GLOBENEWSWIRE
BioAegis Leverages Gelsolin’s Broad Therap. Applicability Inflammatory Diseases
06 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.